Trial Outcomes & Findings for Technology Intensified Diabetes Education Study in African Americans (NCT NCT02088658)

NCT ID: NCT02088658

Last Updated: 2026-03-06

Results Overview

Hemoglobin A1c (HbA1c): blood specimens collected at the 12-months follow-up visit

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

200 participants

Primary outcome timeframe

12 months post randomization

Results posted on

2026-03-06

Participant Flow

Participant milestones

Participant milestones
Measure
Techonology Intensified
Subjects randomized to this group will receive: 1) the FORA system for self-monitoring; 2) weekly telephone-delivered diabetes education/skills training; 3) patient activation (list of 5 questions to ask their provider at every visit and training on how to ask the questions); and 4) patient empowerment (diabetes responsibility contracts, personal goals, and flow charts for patients to record lab results/medications and training on how to use the empowerment tools). The intervention will be delivered by telephone once a week for 12 weeks with each session lasting \~30 minutes. Technology Intensified: The intervention is based on the Information-Motivation-Behavioral Skills (IMB) model and provides information, motivation, and behavioral skills training (using motivational enhancement techniques). Patients will be assigned the FORA 2-in-1 Telehealth System and provided glucose test strips to allow testing at least once a day. They will be asked to perform glucose testing and blood pressure measurement using the FORA system once daily. They will be asked to upload the measurements daily as soon as possible after the test is performed. The nurse educators will have access to a secure server to which the uploaded measurements are stored in real time. The glucose and BP readings will be used to tailor and reinforce behavior change during weekly telephone-delivered diabetes education sessions.
Usual Care
Apart from study visits, patients will be followed by their primary care providers. The provider will be responsible for determining treatment parameters, making changes in the treatment regimen, and determining the timing of follow up visits. Between scheduled office encounters, contact between patient and provider will be patient initiated. The provider may use clinic nurses to follow up on problematic patients or patients with abnormal results. In essence, this group will receive the current standard of care at the study clinics.
Overall Study
STARTED
95
105
Overall Study
COMPLETED
85
94
Overall Study
NOT COMPLETED
10
11

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Technology Intensified Diabetes Education Study in African Americans

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Usual Care
n=105 Participants
Apart from study visits, patients will be followed by their primary care providers. The provider will be responsible for determining treatment parameters, making changes in the treatment regimen, and determining the timing of follow up visits. Between scheduled office encounters, contact between patient and provider will be patient initiated. The provider may use clinic nurses to follow up on problematic patients or patients with abnormal results. In essence, this group will receive the current standard of care at the study clinics.
Total
n=200 Participants
Total of all reporting groups
Techonology Intensified
n=95 Participants
Subjects randomized to this group will receive: 1) the FORA system for self-monitoring; 2) weekly telephone-delivered diabetes education/skills training; 3) patient activation (list of 5 questions to ask their provider at every visit and training on how to ask the questions); and 4) patient empowerment (diabetes responsibility contracts, personal goals, and flow charts for patients to record lab results/medications and training on how to use the empowerment tools). The intervention will be delivered by telephone once a week for 12 weeks with each session lasting \~30 minutes. Technology Intensified: The intervention is based on the Information-Motivation-Behavioral Skills (IMB) model and provides information, motivation, and behavioral skills training (using motivational enhancement techniques). Patients will be assigned the FORA 2-in-1 Telehealth System and provided glucose test strips to allow testing at least once a day. They will be asked to perform glucose testing and blood pressure measurement using the FORA system once daily. They will be asked to upload the measurements daily as soon as possible after the test is performed. The nurse educators will have access to a secure server to which the uploaded measurements are stored in real time. The glucose and BP readings will be used to tailor and reinforce behavior change during weekly telephone-delivered diabetes education sessions.
Age, Categorical
<=18 years
0 Participants
n=35 Participants
0 Participants
n=76 Participants
0 Participants
n=41 Participants
Age, Categorical
Between 18 and 65 years
89 Participants
n=35 Participants
177 Participants
n=76 Participants
88 Participants
n=41 Participants
Age, Categorical
>=65 years
16 Participants
n=35 Participants
23 Participants
n=76 Participants
7 Participants
n=41 Participants
Age, Continuous
56.8 years
STANDARD_DEVIATION 12.7 • n=35 Participants
56.2 years
STANDARD_DEVIATION 11.8 • n=76 Participants
55.6 years
STANDARD_DEVIATION 10.8 • n=41 Participants
Sex: Female, Male
Female
73 Participants
n=35 Participants
133 Participants
n=76 Participants
60 Participants
n=41 Participants
Sex: Female, Male
Male
32 Participants
n=35 Participants
67 Participants
n=76 Participants
35 Participants
n=41 Participants
Race/Ethnicity, Customized
Non-Hispanic Black
105 Participants
n=35 Participants
200 Participants
n=76 Participants
95 Participants
n=41 Participants
Region of Enrollment
United States
105 Participants
n=35 Participants
200 Participants
n=76 Participants
95 Participants
n=41 Participants
Hemoglobin A1c
10.3 mean percentage of HbA1c
STANDARD_DEVIATION 1.8 • n=35 Participants
10.3 mean percentage of HbA1c
STANDARD_DEVIATION 1.8 • n=76 Participants
10.4 mean percentage of HbA1c
STANDARD_DEVIATION 1.8 • n=41 Participants

PRIMARY outcome

Timeframe: 12 months post randomization

Hemoglobin A1c (HbA1c): blood specimens collected at the 12-months follow-up visit

Outcome measures

Outcome measures
Measure
Techonology Intensified
n=95 Participants
Subjects randomized to this group will receive: 1) the FORA system for self-monitoring; 2) weekly telephone-delivered diabetes education/skills training; 3) patient activation (list of 5 questions to ask their provider at every visit and training on how to ask the questions); and 4) patient empowerment (diabetes responsibility contracts, personal goals, and flow charts for patients to record lab results/medications and training on how to use the empowerment tools). The intervention will be delivered by telephone once a week for 12 weeks with each session lasting \~30 minutes. Technology Intensified: The intervention is based on the Information-Motivation-Behavioral Skills (IMB) model and provides information, motivation, and behavioral skills training (using motivational enhancement techniques). Patients will be assigned the FORA 2-in-1 Telehealth System and provided glucose test strips to allow testing at least once a day. They will be asked to perform glucose testing and blood pressure measurement using the FORA system once daily. They will be asked to upload the measurements daily as soon as possible after the test is performed. The nurse educators will have access to a secure server to which the uploaded measurements are stored in real time. The glucose and BP readings will be used to tailor and reinforce behavior change during weekly telephone-delivered diabetes education sessions.
Usual Care
n=105 Participants
Apart from study visits, patients will be followed by their primary care providers. The provider will be responsible for determining treatment parameters, making changes in the treatment regimen, and determining the timing of follow up visits. Between scheduled office encounters, contact between patient and provider will be patient initiated. The provider may use clinic nurses to follow up on problematic patients or patients with abnormal results. In essence, this group will receive the current standard of care at the study clinics.
Hemoglobin A1c
9.8 mean percent of HbA1c
Standard Deviation 2.1
9.6 mean percent of HbA1c
Standard Deviation 1.7

Adverse Events

Techonology Intensified

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Usual Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Principal Investigator

SUNY at Buffalo

Phone: 716-829-2364

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place